Ola Landgren
MD, PhD
Chief of Myeloma Service
👥Biography 个人简介
Ola Landgren is a leading myeloma researcher renowned for his work on minimal residual disease (MRD) as a biomarker for treatment response and survival. He established the importance of MRD negativity as a surrogate endpoint in myeloma clinical trials. His research on smoldering multiple myeloma and MGUS progression has transformed early intervention strategies. He is a pioneer in applying next-generation sequencing and flow cytometry to achieve deep remissions in myeloma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ola Landgren 的研究动态
Follow Ola Landgren's research updates
留下邮箱，当我们发布与 Ola Landgren（University of Miami Sylvester Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment